- Report
- April 2025
- 71 Pages
China
From €1587EUR$1,800USD£1,394GBP
- Report
- January 2025
- 24 Pages
India
From €995EUR$1,209USD£905GBP
- Report
- September 2024
- 231 Pages
China
From €3526EUR$4,000USD£3,097GBP
- Clinical Trials
- July 2024
- 745 Pages
Global
From €3042EUR$3,450USD£2,671GBP
- Report
- July 2024
- 116 Pages
Global
From €3967EUR$4,500USD£3,485GBP
- Report
- July 2024
- 19 Pages
Global
From €13220EUR$14,995USD£11,611GBP
- Clinical Trials
- April 2024
- 390 Pages
Global
From €2204EUR$2,500USD£1,936GBP
- Report
- January 2024
- 113 Pages
United States
€3086EUR$3,500USD£2,710GBP
- Report
- June 2023
- 27 Pages
Global
€10800EUR$12,250USD£9,486GBP
- Report
- March 2023
- 30 Pages
Global
€10800EUR$12,250USD£9,486GBP
- Report
- February 2023
- 27 Pages
Global
€10800EUR$12,250USD£9,486GBP
- Report
- November 2022
- 103 Pages
Global
From €3482EUR$3,950USD£3,059GBP
- Training
- 90 Minutes
Global
- Report
- August 2025
- 157 Pages
Global
From €3110EUR$3,528USD£2,731GBP
€3659EUR$4,150USD£3,213GBP
- Report
- December 2022
- 30 Pages
Global
From €1763EUR$2,000USD£1,549GBP
- Report
- November 2022
- 54 Pages
Global
From €1763EUR$2,000USD£1,549GBP
- Report
- September 2022
- 38 Pages
Global
From €1763EUR$2,000USD£1,549GBP
- Report
- May 2022
- 68 Pages
Global
From €1763EUR$2,000USD£1,549GBP
- Report
- February 2022
- 84 Pages
Global
From €3200EUR$3,888USD£2,909GBP
- Report
- December 2025
Global
From €3518EUR$3,990USD£3,090GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more